SCHEMBL12366238

SCHEMBL12366238

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccc(-c3ccccc3)cc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.42
CNR1 P21554 1/20 0.40
RXRA P19793 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PPARG P37231 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGB7 P26010 1/20 0.37
FAAH O00519 2/20 0.37
MGLL Q99685 2/20 0.37
CFTR P13569 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366212 0.95 CNR1 (0.44) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366308 0.93 RXRA (0.43) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366320 0.93 KDM4E (0.47) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366275 0.93 CFTR (0.42) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366245 0.92 CNR1 (0.43) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366313 0.92 CNR1 (0.38) DCTPP1CNR1RXRANR1H2NR1H3
SCHEMBL12366295 0.90 ITGB1 (0.39) DCTPP1CNR1HPGDPPARGALDH1A1
SCHEMBL12366376 0.90 RXRA (0.40) DCTPP1CNR1RXRAHPGDKDM4E
SCHEMBL12366395 0.90 CCR2 (0.44) DCTPP1CNR1HPGDKDM4EPPARG
SCHEMBL12366324 0.90 NR1H2 (0.49) DCTPP1CNR1RXRANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed